Pasithea Therapeutics (KTTA) Other Non Operating Income (2022 - 2026)

Pasithea Therapeutics has reported Other Non Operating Income for 5 years, with the latest figure at -$9491.0 in Q1 2026.

• Quarterly Other Non Operating Income fell 235.59% year-over-year to -$9491.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5365.0 (down 101.37% YoY) and the FY2025 annual result came in at $30376.0, changed N/A from the prior year.
• Other Non Operating Income slipped to -$9491.0 in Q1 2026 per KTTA's latest filing, from $23376.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $153218.0 in Q1 2024 and troughed at -$26250.0 in Q3 2025.
• A 5-year average of $38616.9 and a median of $7000.0 in 2025 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2024 and 2026: Other Non Operating Income jumped 2498.53% in 2024, then plunged 235.59% in 2026.
• Over 5 years, Other Non Operating Income stood at -$277.0 in 2022, then surged by 42407.22% to $117191.0 in 2023, then slipped by 2.38% to $114407.0 in 2024, then slumped by 79.57% to $23376.0 in 2025, then tumbled by 140.6% to -$9491.0 in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered -$9491.0, $23376.0, and -$26250.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.